Podcast: ADAPT SMART & MAPPs from the Patient’s Perspective, with EPF and EURORDIS

On 6 September, Nicola Bedlington from The European Patients Forum (EPF) and Yann Le Cam from Eurordis, two of Europe’s leading patient representatives, discussed the need for Adaptive Pathways (MAPPs) in Europe.

Adaptive Design Laboratory Workshop

1st-2nd June 2016

London, United Kingdom

In June 2016 ADAPT SMART together with MIT NewDigs and GetReal organised a 2-day workshop on the use of real world evidence in decision making and the use of scenarios to explore stakeholder-specific benefit, risk, and uncertainty trade-off decisions and associated impacts throughout the lifespan of the medicinal product.

Preliminary Conclusions Report From 29th February Multi-Stakeholder Workshop

On the 29th of February, ADAPT SMART hosted an invitation-only multi-stakeholder workshop around selection criteria for MAPPs in Amsterdam, The Netherlands. The programme from the event can be found here. A full report of the event will be available in due course. A preliminary overview of conclusions was prepared for the participants in the “Innovation for the [...]

Blog From D2.03 Leaders: Takeaways From the ADAPT SMART Workshop on Selection Criteria for MAPPs

On the 29th of February, ADAPT SMART hosted an invitation-only multi-stakeholder workshop around selection criteria for MAPPs in Amsterdam, The Netherlands. Angelika Joos of MSD and Mathieu Boudes of EURORDIS attended the workshop in their capacity as ADAPT SMART Task 2.03 leaders. Here they share an update on the workshop’s progress. More information about the workshop can [...]

“MAPPs can be a promising way of working”: Podcast with HTA’s and Payers From DIA Hamburg 2016

On 7 April, key participants associated with the IMI ADAPT SMART project met to discuss the consortia's progress in finding ways to implement MAPPs in Europe. Participants included: Hans-Georg Eichler, Senior Medical Officer at the European Medicines Agency (EMA); Luk Maes, Executive Director, Regulatory Scientific Policies – Europe, for Bristol-Myers Squibb; Ad Schuurman, Head of the Business Contact Centre & International Affairs National Health Care Institute of the Netherlands (ZIN); and Sarah Garner Associate Science Policy and Research, National Institute of Health and Care Excellence (NICE).